GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Delivra Health Brands Inc (OTCPK:DHBUF) » Definitions » EV-to-EBITDA

Delivra Health Brands (Delivra Health Brands) EV-to-EBITDA : 4.46 (As of May. 22, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Delivra Health Brands EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Delivra Health Brands's enterprise value is $8.38 Mil. Delivra Health Brands's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $1.88 Mil. Therefore, Delivra Health Brands's EV-to-EBITDA for today is 4.46.

The historical rank and industry rank for Delivra Health Brands's EV-to-EBITDA or its related term are showing as below:

DHBUF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -61.03   Med: -2.02   Max: 6.99
Current: 5.57

During the past 13 years, the highest EV-to-EBITDA of Delivra Health Brands was 6.99. The lowest was -61.03. And the median was -2.02.

DHBUF's EV-to-EBITDA is ranked better than
85.47% of 716 companies
in the Drug Manufacturers industry
Industry Median: 14.56 vs DHBUF: 5.57

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), Delivra Health Brands's stock price is $0.03125. Delivra Health Brands's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.002. Therefore, Delivra Health Brands's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Delivra Health Brands EV-to-EBITDA Historical Data

The historical data trend for Delivra Health Brands's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delivra Health Brands EV-to-EBITDA Chart

Delivra Health Brands Annual Data
Trend Dec14 Dec15 Dec16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.67 -0.51 -3.57 -2.02 1.25

Delivra Health Brands Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.03 1.25 1.15 2.52 -

Competitive Comparison of Delivra Health Brands's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delivra Health Brands's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Delivra Health Brands's EV-to-EBITDA falls into.



Delivra Health Brands EV-to-EBITDA Calculation

Delivra Health Brands's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=8.382/1.88
=4.46

Delivra Health Brands's current Enterprise Value is $8.38 Mil.
Delivra Health Brands's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Delivra Health Brands  (OTCPK:DHBUF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Delivra Health Brands's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.03125/-0.002
=At Loss

Delivra Health Brands's share price for today is $0.03125.
Delivra Health Brands's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.002.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Delivra Health Brands EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Delivra Health Brands's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Delivra Health Brands (Delivra Health Brands) Business Description

Traded in Other Exchanges
Address
999 Canada Place, Suite 404, Vancouver, BC, CAN, V6C 3E2
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.